Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?

Keeping Current

29-03-2024 • 20 mins

How much do you know about future treatment options for type 2 diabetes (T2D)? Join Drs Vilsbøll and Nauck to find out.

Credit available for this activity expires: 03/27/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000462
?ecd=bdc_podcast_libsyn_mscpedu

You Might Like